These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1059709)

  • 1. Comparative trials of live attenuated and detergent split influenza virus vaccines.
    Mackenzie JS; Mackenzie I; Lloyd J; Dent V
    J Hyg (Lond); 1975 Dec; 75(3):425-43. PubMed ID: 1059709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of cigarette smoking on susceptibility to epidemic influenza and on serological responses to live attenuated and killed subunit influenza vaccines.
    MacKenzie JS; MacKenzie IH; Holt PG
    J Hyg (Lond); 1976 Dec; 77(3):409-17. PubMed ID: 1069819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection.
    Masurel N; Laufer J
    J Hyg (Lond); 1984 Jun; 92(3):263-76. PubMed ID: 6736638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody responses and resistance to challenge in volunteers vaccinated with live attenuated, detergent split and oil adjuvant A2-Hong Kong-68 (H 3 N 2 ) influenza vaccines. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines.
    Freestone DS; Hamilton-Smith S; Schild GC; Buckland R; Chinn S; Tyrrell DA
    J Hyg (Lond); 1972 Sep; 70(3):531-43. PubMed ID: 4506997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A graded-dose study of inactivated, surface antigen influenza B vaccine in volunteers: reactogenicity, antibody response and protection to challenge virus infection.
    Goodeve A; Potter CW; Clark A; Jennings R; Schild GC; Yetts R
    J Hyg (Lond); 1983 Feb; 90(1):107-15. PubMed ID: 6822725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.
    Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
    J Hyg (Lond); 1983 Jun; 90(3):351-9. PubMed ID: 6863909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity.
    Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
    J Hyg (Lond); 1983 Jun; 90(3):361-70. PubMed ID: 6863910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative trial of influenza vaccines. I. Immunogenicity of whole virus and split product vaccines in man.
    Barry DW; Mayner RE; Staton E; Dunlap RC; Rastogi SC; Hannah JE; Blackburn RJ; Nortman DF; Graze PR
    Am J Epidemiol; 1976 Jul; 104(1):34-46. PubMed ID: 947145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new surface-antigen-adsorbed influenza virus vaccine. II. Studies in a volunteer group.
    Potter CW; Jennings R; McLaren C; Edey D; Stuart-Harris CH; Brady M
    J Hyg (Lond); 1975 Dec; 75(3):353-62. PubMed ID: 1059705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuated influenza A vaccine (Alice) in an adult population: vaccine-related illness, serum and nasal antibody production, and intrafamily transmission.
    Minor TE; Dick EC; Dick CR; Inhorn SL
    J Clin Microbiol; 1975 Nov; 2(5):403-9. PubMed ID: 1104655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of ABO blood groups on the incidence of epidemic influenza and on the response to live attenuated and detergent split influenza virus vaccines.
    Mackenzie JS; Fimmel PJ
    J Hyg (Lond); 1978 Feb; 80(1):21-30. PubMed ID: 621379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines.
    Potter CW; Jennings R; Nicholson K; Tyrrell DA; Dickinson KG
    J Hyg (Lond); 1977 Dec; 79(3):321-32. PubMed ID: 270523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of an inhibitor-resistant live attenuated influenza vaccine in normal and asthmatic adults.
    Warshauer DM; Minor TE; Inhorn SL; Reed CE; Dick EC
    Dev Biol Stand; 1976; 33():184-90. PubMed ID: 782967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers.
    Heldens J; Hulskotte E; Voeten T; Breedveld B; Verweij P; van Duijnhoven W; Rudenko L; van Damme P; van den Bosch H
    Vaccine; 2014 Sep; 32(39):5118-24. PubMed ID: 24858566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of acute respiratory disease in the community of Port Chalmers. III. Efficacy of influenza virus subunit vaccines in 1973, 1974 and 1975.
    Jennings LC; MacDiarmid RD; Miles JA
    N Z Med J; 1980 Sep; 92(668):230-3. PubMed ID: 6935541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical trial of WRL 105 strain live attenuated influenza vaccine comparing four methods of intranasal vaccination.
    White WG; Freestone DS; Bowker CH; Barnes GM; Letley E; Ferris RD
    Dev Biol Stand; 1976; 33():202-6. PubMed ID: 782970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WRL 105 strain (H3N2) live attenuated influenza vaccine: acceptability, reactivity, and antibody response in normal, bronchitic, and geriatric volunteers.
    Nicholson KG; Tyrrell DA; Freestone DS
    Lancet; 1976 Jun; 1(7973):1309-11. PubMed ID: 58306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live, attenuated influenza A/England/42/72 (H3N2) virus vaccine: a field trial.
    Rubin RJ; Noble GR; Corey L; Brown WJ; Brandling-Bennett D; Kaye HS; Coleman MT; Gregg MB; Dowdle WR
    J Infect Dis; 1976 Jun; 133(6):613-20. PubMed ID: 778302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WRL 105 strain live attenuated influenza vaccine; comparison of one and two dose schedules.
    Evans AE; Letley E; Ferris RD; Freestone DS
    J Hyg (Lond); 1976 Dec; 77(3):327-32. PubMed ID: 1069813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.
    Maruszak H; Jeganathan S; Smith DE; Robertson P; Barnes T; Furner V
    HIV Med; 2012 Jul; 13(6):352-7. PubMed ID: 22296264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.